Mirafuentes, Analyn J.
HRN: 22-34-23 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/16/2022
CEFTRIAXONE 1G (VIAL)
12/16/2022
12/23/2022
IVTT
2g
OD
S/P Pelvic Lap
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes